Italian Nobel scientist Montalcini dies at 103

ROME Sun Dec 30, 2012 2:59pm EST

1 of 3. Italian neurologist Rita Levi Montalcini is seen in this 1984 file photograph. Rita Levi Montalcini, joint winner of the Nobel Prize for Medicine and an Italian Senator for Life, died on Sunday at the age of 103, her family said. The first Nobel laureate to reach 100 years of age, she won the prize in 1986 with American Stanley Cohen for their discovery of nerve growth factor (NGF), a protein that makes developing cells grow by stimulating surrounding nerve tissue.

Credit: Reuters/Stringer/Files

Related Topics

ROME (Reuters) - Rita Levi Montalcini, joint winner of the Nobel Prize for Medicine and an Italian Senator for Life, died on Sunday at the age of 103, her family said.

The first Nobel laureate to reach 100 years of age, she won the prize in 1986 with American Stanley Cohen for their discovery of nerve growth factor (NGF), a protein that makes developing cells grow by stimulating surrounding nerve tissue.

Her research helped in the treatment of spinal cord injuries and has increased understanding of cardiovascular diseases, Alzheimer's and conditions such as dementia and autism.

One of twins born to a Jewish family in Turin in 1909, Montalcini was the oldest living recipient of the prize.

During World War Two, the Allies' bombing of Turin forced her to flee to the countryside where she established a mini-laboratory. She fled to Florence after the German invasion of Italy and lived in hiding there for a while, later working as a doctor in a refugee camp.

After the war she moved to St. Louis in the United States to work at Washington University, where she went on to make her groundbreaking NGF discoveries.

She also set up a research unit in Rome and in 1975 became the first woman to be made a full member of the Vatican's Pontifical Academy of Sciences in 1975. She won several other awards for her contributions to medical and scientific research.

Her face was instantly recognizable in Italy and she was well known as a dignified and respected intellectual, a counterbalance to the image of women succeeding through their looks and sexuality, exacerbated during the scandal-plagued era of former prime minister Silvio Berlusconi.

Two days after her birthday in April this year she posted a note on Facebook saying it was important never to give up on life or fall into mediocrity and passive resignation.

"I've lost a bit of sight, and a lot of hearing. At conferences I don't see the projections and I don't feel good. But I think more now than I did when I was 20. The body does what it wants. I am not the body, I am the mind," she said.

Italian Prime Minister Mario Monti said in a statement that Montalcini's Nobel prize had been an honor for Italy, and praised her efforts to encourage young people, especially women, to play a central role in scientific research.

(Editing by Louise Ireland)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
PamelaRenkei wrote:
Goodbye Rita Montalcini; a beautiful human with a gifted mind. She broke through so much human ignorance; a women scientist in Italy 1950′s and a Jew during the occupation of Italy by Germany. I can’t help but wonder… Couldn’t the 23 year old med student from Delhi, who was so brutally raped and “tortured” have been our next Rita Montalcini? We’ll never know, because she lost her battle and died yesterday….
In India, there are three rapes A DAY – and ONLY 6 convictions a YEAR; a human tragedy.. No other species on this planet, is so consciously self-destructive..

Dec 30, 2012 2:40pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.